[Therapy of endocrine ophthalmopathies].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D004700:Endocrine System Diseases / Q000150:complications* / Q000628:therapy; D005094:Exophthalmos / Q000628:therapy; D005132:Eye Manifestations / Q000628:therapy*; D005143:Eyelids; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D006980:Hyperthyroidism / Q000532:radiotherapy; D007400:Interprofessional Relations; D009883:Ophthalmic Solutions / Q000627:therapeutic use; D010900:Pituitary Diseases / Q000532:radiotherapy / Q000628:therapy; D011241:Prednisone / Q000627:therapeutic use; D013959:Thyroid Diseases / Q000628:therapy; D013972:Thyrotropin / Q000037:antagonists & inhibitors; D013974:Thyroxine / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D009883:Ophthalmic Solutions; D013972:Thyrotropin; D013974:Thyroxine; D011241:Prednisone; D006145:Guanethidine
Therapie der endokrinen Ophthalmopathie.